Trevor Snyder Ph.D.

Trevor Snyder, Ph.D. is a Clinical Bioengineer for the Mechanical Circulatory Support Program of the Advanced Cardiac Care Initiative with the Nazih Zudhi Transplant Institute.  Dr. Snyder is an expert in ventricular assist devices (VAD) and provides guidance on operation and optimization of performance in our patients.  In addition, he is an active researcher in the field of biocompatibility, that is, the biologic responses VADs produce in the body, particularly thrombosis (blood clotting) and inflammation.  Dr. Snyder was previously a Clinical VAD Engineer and Director of the Clinical Biocompatibility Laboratory at the University of Maryland School of Medicine.  Dr. Snyder joined INTEGRIS in October 2008.

Dr. Snyder is originally from Tulsa, Oklahoma and graduated from Holland Hall School.  He earned a degree in Biomedical Engineering from Tulane University in New Orleans, Louisiana, where he was a Dean’s Honor Scholar and graduated with departmental honors.  Dr. Snyder then pursued a Ph.D. in Bioengineering at the University of Pittsburgh.  His thesis study focused on assessing the biocompatibility of artificial organs, particularly VADs and artificial lungs, in preclinical trials.  One of those devices is now called the Heartmate II and is employed here at INTEGRIS.

While attending graduate school, Dr. Snyder served as an Artificial Heart Bioengineer in the Artificial Heart Program at the University of Pittsburgh Medical Center.  After graduation, Dr. Snyder remained in Pittsburgh to continue working on the PediaFlow project, developing a VAD for infants and small children, and was promoted to Senior Biomedical Engineer in the Artificial Heart Program.  In 2007 Dr. Snyder joined the University of Maryland School of Medicine as a Clinical VAD Engineer and Research Associate.  He was soon thereafter appointed Director of the Clinical Biocompatibility Laboratory.

Dr. Snyder has helped support over 250 VAD and total artificial heart implants using over a dozen different devices.  He has authored or coauthored 13 publications related to VAD development and biocompatibility and delivered over 50 national presentations on the topic.

As part of the Advanced Cardiac Care team, Dr. Snyder will provide support to our VAD patients and continue his translational research into improving patient outcomes and reducing device-related complications.